Research Analysts Issue Forecasts for TerrAscend Q2 Earnings

Key Points

• Ventum Capital Markets has revised its Q2 2025 earnings estimate for TerrAscend Corp., projecting a loss of ($0.02) per share, down from the previous estimate of ($0.01).
• TerrAscend reported Q2 earnings of ($0.03) per share, missing analyst expectations by ($0.01) and experiencing a negative net margin of 25.27%.
• Despite the earnings downgrade, Atb Capital Markets upgraded TerrAscend from a "hold" rating to a "strong-buy" rating earlier this year.

TerrAscend Corp. (OTCMKTS:TSNDF - Free Report) - Ventum Cap Mkts cut their Q2 2025 earnings per share estimates for TerrAscend in a report issued on Wednesday, August 6th. Ventum Cap Mkts analyst A. Semple now anticipates that the company will earn ($0.02) per share for the quarter, down from their previous forecast of ($0.01). The consensus estimate for TerrAscend's current full-year earnings is ($0.14) per share. Ventum Cap Mkts also issued estimates for TerrAscend's Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.02) EPS, FY2025 earnings at ($0.09) EPS and FY2026 earnings at ($0.04) EPS.

Separately, Atb Cap Markets upgraded shares of TerrAscend from a "hold" rating to a "strong-buy" rating in a report on Thursday, May 8th.

TerrAscend Stock Up 2.7%

TSNDF traded up $0.02 on Friday, hitting $0.77. The company had a trading volume of 1,061,898 shares, compared to its average volume of 638,590. The company has a debt-to-equity ratio of 1.94, a current ratio of 1.45 and a quick ratio of 1.07. TerrAscend has a 52-week low of $0.23 and a 52-week high of $1.75. The stock has a fifty day simple moving average of $0.35 and a 200-day simple moving average of $0.40. The firm has a market capitalization of $235.68 million, a P/E ratio of -1.88 and a beta of 1.39.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.01). The company had revenue of $65.01 million for the quarter, compared to the consensus estimate of $64.87 million. TerrAscend had a negative net margin of 40.86% and a negative return on equity of 23.19%.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.